The prespecified clinical question was as follows: “Is insulin Icodec more effective and safer than once-daily basal analogs in improving glycemic parameters of patients with diabetes mellitus who failed to achieve glucose control with non-insulin agents or previous insulin treatment?”. Here, INS is linked to diabetes mellitus.